This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chengdu Mfs Pharma. Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Zhenbiao Xie in Anesthetic Compounds
Introduction
Zhenbiao Xie is a notable inventor based in Chengdu, China. He has made significant contributions to the field of anesthetic compounds, particularly through his innovative research and development of substituted nitrogen heterocyclic compounds. His work has the potential to impact clinical practices in anesthesia and sedation.
Latest Patents
Zhenbiao Xie holds a patent for a substituted nitrogen heterocyclic compound and its anesthetic effects. The invention discloses a chemical compound that exhibits good central nervous system inhibition effects. This compound is capable of generating sedative, hypnotic, and general anesthetic effects, as well as controlling status epilepticus. The compound is characterized by a rapid onset of action and quick recovery, while maintaining positive anesthetic activity. Additionally, it has minimal inhibitory effects on adrenocortical function and low side effects, addressing technical challenges in the field.
Career Highlights
Zhenbiao Xie is associated with Chengdu Mfs Pharma Co., Ltd., where he continues to advance his research in anesthetic drugs. His work is crucial for the development of new clinical options for sedative and anesthetic medications.
Collaborations
Zhenbiao Xie collaborates with Jin Liu, contributing to the innovative research environment at Chengdu Mfs Pharma Co., Ltd. Their partnership enhances the potential for breakthroughs in anesthetic drug development.
Conclusion
Zhenbiao Xie's contributions to the field of anesthetics through his patented innovations demonstrate his commitment to improving medical practices. His work not only addresses existing challenges but also opens new avenues for clinical applications in anesthesia.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile